Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,516
Total Claims
$1.6M
Drug Cost
631
Beneficiaries
$2,551
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,825 Geriatric Medicine providers
-24%
Opioid rate vs peers
1.9% vs 2.6% avg
+106%
Cost per patient vs peers
$2,551 vs $1,237 avg
+91%
Brand preference vs peers
17.5% vs 9.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.9%
Opioid Rate
244
Opioid Claims
$5,924
Opioid Cost
12.7%
Long-Acting Rate
Brand vs Generic
Brand: 2,178 claims · $1.2M
Generic: 10,243 claims · $404K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 386 | $180K |
| Pimavanserin Tartrate | 51 | $118K |
| Semaglutide | 96 | $99K |
| Sitagliptin Phosphate | 83 | $89K |
| Imatinib Mesylate | 15 | $65K |
| Rivaroxaban | 150 | $62K |
| Collagenase Clostridium Hist. | 63 | $53K |
| Dulaglutide | 30 | $36K |
| Rifaximin | 23 | $36K |
| Sacubitril/Valsartan | 42 | $36K |
| Tolvaptan | 11 | $35K |
| Brivaracetam | 30 | $27K |
| Empagliflozin | 59 | $27K |
| Linaclotide | 27 | $26K |
| Lacosamide | 49 | $22K |
Prescribing Profile
Patient Profile
78
Avg Age
69%
Female
1.79
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About